No business profile yet.
Size Ellenbarrie Industrial Gases (ELLEN.NS) is an India Materials company (Chemicals: Specialty) with a market value of $420M, the 927th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹278.60 on 18 Nov 2026.
Performance Over six months the shares fell 0.3%, against -18.0% for the median peer and +3.8% for the India market (cap-weighted) — 6th highest of 21 in its peer set.
Growth Revenue grew 289.1% over the last twelve months (peer median +8.0%); the operating margin is 27.8% (peer median 3.2%).
Valuation It trades at 24.6× forward earnings against a peer median of 16.5× (3rd most expensive of 8).
Price implies For today's price to make sense, revenue must grow about 43% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is +28 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 8.4 points below its cost of capital (15.5% WACC).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹3.82B | ₹3.42B | ₹3.12B | ₹2.69B | ₹2.05B |
| Revenue growth | — | +9% | +16% | +31% | — |
| Gross profit | ₹1.95B | ₹1.57B | ₹1.35B | ₹977M | ₹665M |
| EBITDA | ₹1.30B | ₹1.21B | ₹1.11B | ₹626M | ₹346M |
| Net income | ₹1.20B | ₹1.04B | ₹833M | ₹453M | ₹281M |
| Free cash flow | n/a | ₹26.7M | -₹539M | -₹351M | -₹508M |
| Capital expenditure | n/a | ₹1.58B | ₹692M | ₹2.44B | ₹1.99B |
| Total debt | ₹1.43B | ₹1.84B | ₹2.47B | ₹1.78B | ₹1.03B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ELLEN.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -14.7% | -10.0% | 5th lowest of 21 |
| 6-month return | -0.3% | -18.0% | 6th highest of 21 |
| Distance from 52-week high | -38.2% | -39.0% | 11th highest of 21 |
| Revenue growth (TTM) | +289.1% | +8.0% | highest of 21 |
| Operating margin | 27.8% | 3.2% | 2nd highest of 21 |
| Forward P/E | 24.6× | 16.5× | 3rd most expensive of 8 |
| Growth the price implies (Req g, 7 yrs) | 42.8% | 12.7% | 2nd most demanding of 11 |
| Growth delivered (Del g) | +14.3% | +4.3% | 3rd highest of 11 |
| Hurdle (Req g minus delivered) | +28.5 pp | -4.7 pp | 3rd most demanding of 11 |
| ROIC minus cost of capital | -8.4 pp | -2.2 pp | 3rd lowest of 21 |
| EV / EBITDA | 30.6× | 12.8× | 2nd most expensive of 6 |
| Net debt / EBITDA | 0.5× | 5.3× | 3rd least indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Ellenbarrie Industrial Gases ELLEN.NS | India | $420M | 0% | +289% | 28% | 24.6× | 42.8% | +14.3% |
| Gevo GEVO | United States | $421M | +4% | +80% | -11% | 24.8× | n/a | n/a |
| Braskem S.A. Sponsored ADR Pfd BAK | United States | $421M | -82% | -1% | 1% | 1.6× | n/a | n/a |
| FuJian Nox Bellcow 300132.SZ | China | $422M | -32% | +18% | 7% | 16.5× | -4.3% | -10.5% |
| Koatsu Gas Kogyo 4097.T | Japan | $423M | +10% | +4% | 7% | n/a | -9.6% | +5.1% |
| Nantong Jiangtian Chemical 300927.SZ | China | $425M | -32% | +51% | 5% | n/a | 16.3% | +29.0% |
| Guangdong Tianan New Material 603725.SS | China | $425M | -10% | -12% | 2% | n/a | 19.4% | +29.0% |
| Shanghai Huide Science & Technology 603192.SS | China | $426M | -22% | +10% | 3% | n/a | 9.0% | +10.5% |
| Tatva Chintan Pharma Chem TATVA.NS | India | $412M | +29% | +50% | 13% | 49.8× | n/a | n/a |
| Guangdong Delian 002666.SZ | China | $410M | -30% | +3% | 0% | n/a | n/a | n/a |
| Oriental Union Chemical 1710.TW | Taiwan | $409M | +41% | +1% | 0% | 16.1× | n/a | n/a |
| Baotou Dongbao Bio-Tech 300239.SZ | China | $408M | -14% | +7% | 7% | n/a | n/a | n/a |
| UPC Technology 1313.TW | Taiwan | $435M | +9% | -1% | 0% | n/a | 38.2% | +2.5% |
| KPIC 006650.KS | South Korea | $405M | -40% | +11% | 4% | 8.9× | n/a | n/a |
| Zhejiang Haisen Pharmaceutical 001367.SZ | China | $404M | -24% | +9% | 29% | n/a | -3.9% | +13.4% |
| Zhejiang Jianye Chemical 603948.SS | China | $438M | -36% | -5% | 12% | n/a | -4.3% | +3.5% |
| Qingdao Copton Technology 603798.SS | China | $401M | -43% | -7% | 5% | n/a | 19.9% | +0.9% |
| Shenyang Chemical Industry 000698.SZ | China | $443M | -4% | +18% | 1% | n/a | n/a | n/a |
| Hubei Shuanghuan Science and Technology 000707.SZ | China | $399M | -11% | -10% | -10% | n/a | 56.5% | +3.1% |
| Changhua Chemical Technology 301518.SZ | China | $443M | -44% | +17% | -2% | n/a | n/a | n/a |
| Vishnu Chemicals VISHNU.NS | India | $398M | -8% | +14% | 13% | 20.1× | n/a | n/a |